#Research
Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer doi.org/10.1186/s435...
#TNBC #TTNinactivation #MDSCs #GlycolyticMetabolism #DLL4_MCT4
Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer doi.org/10.1186/s435...
#TNBC #TTNinactivation #MDSCs #GlycolyticMetabolism #DLL4_MCT4
Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer - Molecular Biomedicine
Triple-negative breast cancer (TNBC) is characterized by complex genomic background and treatment resistance. We first defined “Titin (TTN) inactivation”, a state of TTN expression deficiency or mutat...
doi.org
December 12, 2025 at 9:01 AM
#Research
Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer doi.org/10.1186/s435...
#TNBC #TTNinactivation #MDSCs #GlycolyticMetabolism #DLL4_MCT4
Delta-like ligand 4 mediated myeloid-derived suppressor cell metabolic reprogramming promotes neoadjuvant therapy resistance in titin-inactivated triple-negative breast cancer doi.org/10.1186/s435...
#TNBC #TTNinactivation #MDSCs #GlycolyticMetabolism #DLL4_MCT4